Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Operating Expenses | 7,643 | 6,440 | 5,298 | 4,868 | 2,803 |
| Operating Income | -7,643 | -6,440 | -5,298 | -4,868 | -2,803 |
| Other Income | 8 | 73 | 0 | 1 | 5 |
| Pre-tax Income | -7,635 | -6,367 | -5,298 | -4,867 | -2,798 |
| Net Income Continuous | -7,635 | -6,367 | -5,298 | -4,867 | -2,798 |
| Net Income | $-7,635 | $-6,367 | $-5,298 | $-4,867 | $-2,798 |
| EPS Basic Total Ops | -0.16 | -0.14 | -0.14 | -0.17 | -0.11 |
| EPS Basic Continuous Ops | -0.16 | -0.14 | -0.14 | -0.18 | -0.11 |
| EPS Diluted Total Ops | -0.16 | -0.14 | -0.14 | -0.17 | -0.11 |
| EPS Diluted Continuous Ops | -0.16 | -0.14 | -0.14 | -0.18 | -0.11 |
| EBITDA(a) | $-7,377 | $-6,200 | $-5,113 | $-4,803 | $-2,798 |